{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:53:43Z","timestamp":1791849223420,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Canadian Safety and Security Program","award":["CSSP-2019-CP-2449"],"award-info":[{"award-number":["CSSP-2019-CP-2449"]}]},{"name":"Canadian Safety and Security Program","award":["CSSP-2019-CP-2449"],"award-info":[{"award-number":["CSSP-2019-CP-2449"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Orthoebolaviruses, like Ebola, Sudan, and Bundibugyo viruses, are responsible for causing sporadic and unpredictable outbreaks of severe disease throughout Sub-Saharan Africa. Accurate and reliable diagnostic tests are key to identifying cases of disease and restricting its spread, yet options are mostly limited to molecular assays, such as reverse transcriptase quantitative PCR, that require time, training, and complex equipment to run. To complement existing diagnostic modalities, and to address some of their shortcomings, we developed a prototype immunochromatographic lateral flow rapid diagnostic test (ILF-RDT) that detects the glycoproteins (GPs) from all known orthoebolaviruses, including Bundibugyo virus, which is currently causing a large outbreak in the Democratic Republic of the Congo and Uganda. This test depends on a pair of novel, broadly cross-reactive monoclonal antibodies capable of binding the viral GP\u2014including the secreted GP\u2014in a non-competitive manner. Here, we show that this ILF-RDT detects both recombinant GP and authentic virus in a variety of substrates, including samples spiked with human blood and blood samples taken from experimentally infected animals. Indeed, the ILF-RDT was able to detect Ebola virus in nonhuman primate samples at 4 days post-infection, before the animals began exhibiting signs of severe disease. Given the uniquely broad cross-reactivity of this diagnostic assay, its ability to detect low levels of virus early during infection, and its suitability for use at the point-of-care in resource-limited settings, this ILF-RDT could have a significant impact on the management and mitigation of future orthoebolavirus outbreaks.<\/jats:p>","DOI":"10.1038\/s44298-026-00209-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:45:30Z","timestamp":1782276330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of an immunochromatographic lateral flow assay for the rapid detection of all known orthoebolavirus glycoproteins"],"prefix":"10.1038","volume":"4","author":[{"given":"Helene","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Wight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Emeterio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mable","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Banadyga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"209_CR1","unstructured":"Kuhn, J. H., Amarasinghe, G. K. & Perry, D. L. Filoviridae. in Fields Virology 449\u2013503 (Wolters Kluver, 2021)."},{"key":"209_CR2","doi-asserted-by":"crossref","unstructured":"Munyeku-Bazitama, Y., Edidi-Atani, F. & Takada, A. Non-Ebola Filoviruses: potential threats to global health security. Viruses 16, 1179 (2024).","DOI":"10.3390\/v16081179"},{"key":"209_CR3","doi-asserted-by":"publisher","first-page":"2164216","DOI":"10.1080\/22221751.2022.2164216","volume":"12","author":"BS Bodmer","year":"2023","unstructured":"Bodmer, B. S. et al. In vivo characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans. Emerg. Microbes Infect. 12, 2164216 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"209_CR4","doi-asserted-by":"crossref","unstructured":"Jacob, S. T. et al. Ebola virus disease. Nat. Rev. Dis. Primers 6, 13 (2020).","DOI":"10.1038\/s41572-020-0147-3"},{"key":"209_CR5","unstructured":"World Health Organization. Ebola virus disease. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ebola-virus-disease (2023)."},{"key":"209_CR6","doi-asserted-by":"publisher","first-page":"20160297","DOI":"10.1098\/rstb.2016.0297","volume":"372","author":"CEM Coltart","year":"2017","unstructured":"Coltart, C. E. M., Lindsey, B., Ghinai, I., Johnson, A. M. & Heymann, D. L. The Ebola outbreak, 2013\u20132016: old lessons for new epidemics. Philos. Trans. R. Soc. B 372, 20160297 (2017).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"209_CR7","unstructured":"World Health Organization. Ebola outbreak 2018-2020 North Kivu, Ituri. https:\/\/www.who.int\/emergencies\/situations\/Ebola-2019-drc- (2020)."},{"key":"209_CR8","unstructured":"World Health Organization. Disease Outbreak News. Sudan Virus Disease - Uganda https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON566 (2025)."},{"key":"209_CR9","unstructured":"World Health Organization. Disease Outbreak News. Ebola Virus Disease - Democratic Republic of the Congo https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON589 (2025)."},{"key":"209_CR10","unstructured":"World Health Organization. Ebola Disease: Current Situation. Accessed 27 May 2026. https:\/\/www.cdc.gov\/ebola\/situation-summary\/index.html (2026)."},{"key":"209_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.aca.2020.10.009","volume":"1146","author":"ML Everitt","year":"2021","unstructured":"Everitt, M. L. et al. A critical review of point-of-care diagnostic technologies to combat viral pandemics. Anal. Chim. Acta 1146, 184\u2013199 (2021).","journal-title":"Anal. Chim. Acta"},{"key":"209_CR12","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2471\/BLT.18.219691","volume":"97","author":"D Ming","year":"2019","unstructured":"Ming, D. et al. Connectivity of rapid-testing diagnostics and surveillance of infectious diseases. Bull. World Health Organ 97, 242\u2013244 (2019).","journal-title":"Bull. World Health Organ"},{"key":"209_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2471\/BLT.21.287496","volume":"100","author":"BA Muzembo","year":"2022","unstructured":"Muzembo, B. A. et al. Rapid diagnostic tests versus RT\u2013PCR for Ebola virus infections: a systematic review and meta-analysis. Bull. World Health Organ 100, 447\u2013458 (2022).","journal-title":"Bull. World Health Organ"},{"key":"209_CR14","doi-asserted-by":"crossref","unstructured":"Grolla, A. Real-time and end-point PCR diagnostics for Ebola virus. in Ebolaviruses: Methods and Protocols (eds Hoenen, T. & Groseth, A.) 1628 (Humana Press, 2017).","DOI":"10.1007\/978-1-4939-7116-9_27"},{"key":"209_CR15","doi-asserted-by":"crossref","unstructured":"Bettini, A., Lapa, D. & Garbuglia, A. R. Diagnostics of Ebola virus. Front. Public Health 11, 1123024 (2023).","DOI":"10.3389\/fpubh.2023.1123024"},{"key":"209_CR16","doi-asserted-by":"crossref","unstructured":"Bonney, L. C. et al. A flexible format LAMP assay for rapid detection of Ebola virus. PLoS Negl. Trop. Dis. 14, e0008496 (2020).","DOI":"10.1371\/journal.pntd.0008496"},{"key":"209_CR17","doi-asserted-by":"crossref","unstructured":"James, A. S., Todd, S., Pollak, N. M., Marsh, G. A. & Macdonald, J. Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future. Virol. J. 15, 75 (2018).","DOI":"10.1186\/s12985-018-0985-8"},{"key":"209_CR18","doi-asserted-by":"crossref","unstructured":"Kim, M. J., Haizan, I., Ahn, M. J., Park, D.-H. & Choi, J.-H. Recent advances in lateral flow assays for viral protein detection with nanomaterial-based optical sensors. Biosensors 14, 197 (2024).","DOI":"10.3390\/bios14040197"},{"key":"209_CR19","doi-asserted-by":"crossref","unstructured":"Semper, A. E. et al. Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in sierra leone: a field evaluation study. PLoS Med. 13, e1001980 (2016).","DOI":"10.1371\/journal.pmed.1001980"},{"key":"209_CR20","doi-asserted-by":"crossref","unstructured":"Gay-Andrieu, F. Clinical evaluation of the BioFire FilmArray\u00ae BioThreat-E test for the diagnosis of Ebola Virus Disease in Guinea. J. Clin. Virol. 92, 20\u201324 (2017).","DOI":"10.1016\/j.jcv.2017.04.015"},{"key":"209_CR21","doi-asserted-by":"publisher","first-page":"e0003734","DOI":"10.1371\/journal.pntd.0003734","volume":"9","author":"AC Chua","year":"2015","unstructured":"Chua, A. C., Cunningham, J., Moussy, F., Perkins, M. D. & Formenty, P. The case for improved diagnostic tools to control Ebola virus disease in West Africa and how to get there. PLoS Negl. Trop. Dis. 9, e0003734 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"209_CR22","doi-asserted-by":"crossref","unstructured":"Alhabbab, R. Y. Lateral flow immunoassays for detecting viral infectious antigens and antibodies. Micromachines 13, 1901 (2022).","DOI":"10.3390\/mi13111901"},{"key":"209_CR23","doi-asserted-by":"publisher","first-page":"S691","DOI":"10.1093\/infdis\/jiad205","volume":"228","author":"G Liu","year":"2023","unstructured":"Liu, G. et al. A Pan-Ebolavirus monoclonal antibody cocktail provides protection against Ebola and Sudan Viruses. J. Infect. Dis. 228, S691\u2013S700 (2023).","journal-title":"J. Infect. Dis."},{"key":"209_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/v11110999","volume":"11","author":"W Zhu","year":"2019","unstructured":"Zhu, W., Banadyga, L., Emeterio, K., Wong, G. & Qiu, X. The Roles of Ebola virus soluble glycoprotein in replication, pathogenesis, and countermeasure development. Viruses 11, 999 (2019).","journal-title":"Viruses"},{"key":"209_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/v11070589","volume":"11","author":"S Makiala","year":"2019","unstructured":"Makiala, S. et al. Clinical Evaluation of QuickNaviTM-Ebola in the 2018 Outbreak of Ebola virus disease in the Democratic Republic of the Congo. Viruses 11, 589 (2019).","journal-title":"Viruses"},{"key":"209_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ab.2015.09.009","volume":"492","author":"E Juntunen","year":"2016","unstructured":"Juntunen, E. et al. Effects of blood sample anticoagulants on lateral flow assays using luminescent photon-upconverting and Eu(III) nanoparticle reporters. Anal. Biochem. 492, 13\u201320 (2016).","journal-title":"Anal. Biochem."},{"key":"209_CR27","doi-asserted-by":"publisher","unstructured":"Bowen, R. A. R. & Remaley, A. T. Interferences from blood collection tube components on clinical chemistry assays. Biochem. Med. 31\u201344 https:\/\/doi.org\/10.11613\/BM.2014.006. (2014).","DOI":"10.11613\/BM.2014.006"},{"key":"209_CR28","doi-asserted-by":"publisher","first-page":"116568","DOI":"10.1016\/j.diagmicrobio.2024.116568","volume":"111","author":"DM Emperador","year":"2025","unstructured":"Emperador, D. M., Kelly-Cirino, C., Bausch, D. G. & Eckerle, I. Systematic review and meta-analysis of antigen rapid diagnostic tests to detect Zaire ebolavirus. Diagn. Microbiol. Infect. Dis. 111, 116568 (2025).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"209_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cmi.2022.09.014","volume":"29","author":"AB Dagens","year":"2023","unstructured":"Dagens, A. B., Rojek, A., Sigfrid, L. & Pl\u00fcddemann, A. The diagnostic accuracy of rapid diagnostic tests for Ebola virus disease: a systematic review. Clin. Microbiol. Infect. 29, 171\u2013181 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"209_CR30","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1093\/infdis\/jiw261","volume":"214","author":"ML Boisen","year":"2016","unstructured":"Boisen, M. L. et al. Field Validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J. Infect. Dis. 214, S203\u2013S209 (2016).","journal-title":"J. Infect. Dis."},{"key":"209_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0140-6736(15)61042-X","volume":"386","author":"MJ Broadhurst","year":"2015","unstructured":"Broadhurst, M. J. et al. ReEBOV antigen rapid test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet 386, 867\u2013874 (2015).","journal-title":"Lancet"},{"key":"209_CR32","doi-asserted-by":"publisher","first-page":"S210","DOI":"10.1093\/infdis\/jiw293","volume":"214","author":"RW Cross","year":"2016","unstructured":"Cross, R. W. et al. Analytical validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J. Infect. Dis. 214, S210\u2013S217 (2016).","journal-title":"J. Infect. Dis."},{"key":"209_CR33","unstructured":"U.S. Food and Drug Administration. Evaluation of Automatic Class III Designation for OraQuick Ebola Rapid Antigen Test (DEN190025): Decision Summary. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/DEN190025.pdf (2019)."},{"key":"209_CR34","unstructured":"OraSure Technologies Inc. OraQuick\u00ae Ebola Rapid Antigen Test Customer Letter. https:\/\/orasure.com\/documents\/products\/ebola\/Ebola_Instruction_PI-ENG.pdf (2024)."},{"key":"209_CR35","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1093\/infdis\/jiw252","volume":"214","author":"R Yoshida","year":"2016","unstructured":"Yoshida, R. et al. Development of an immunochromatography assay (QuickNavi-Ebola) to detect multiple species of Ebolaviruses. J. Infect. Dis. 214, S185\u2013S191 (2016).","journal-title":"J. Infect. Dis."},{"key":"209_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cmi.2017.10.019","volume":"24","author":"F Colavita","year":"2018","unstructured":"Colavita, F. et al. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone. Clin. Microbiol. Infect. 24, 653\u2013657 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"209_CR37","doi-asserted-by":"publisher","first-page":"S594","DOI":"10.1093\/infdis\/jiad206","volume":"228","author":"Z Schiffman","year":"2023","unstructured":"Schiffman, Z. et al. The inability of Marburg virus to cause disease in ferrets is not solely linked to the virus glycoprotein. J. Infect. Dis. 228, S594\u2013S603 (2023).","journal-title":"J. Infect. Dis."},{"key":"209_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01438-20","volume":"12","author":"L Banadyga","year":"2021","unstructured":"Banadyga, L. et al. Atypical Ebola virus disease in a nonhuman primate following monoclonal antibody treatment is associated with glycoprotein mutations within the fusion loop. mBio 12, e01438-20 (2021).","journal-title":"mBio"},{"key":"209_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/v15030769","volume":"15","author":"Y Deschambault","year":"2023","unstructured":"Deschambault, Y. et al. An outbred Guinea Pig disease model for lassa fever using a host-adapted clade III Nigerian Lassa Virus. Viruses 15, 769 (2023).","journal-title":"Viruses"},{"key":"209_CR40","doi-asserted-by":"crossref","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25, 2000045 (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"209_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac222","volume":"23","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. ggmsa: a visual exploration tool for multiple sequence alignment and associated data. Brief. Bioinform. 23, bbac222 (2022).","journal-title":"Brief. Bioinform."},{"key":"209_CR42","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/ (2025)."}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00209-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00209-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:20:59Z","timestamp":1791847259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00209-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00209-1","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.S., G.L., and L.B. are listed as co-inventors on U.S. Provisional Patent Application No. 63\/672,450 (filed July 17, 2024) and PCT Application No. PCT\/CA2025\/050985 (filed July 17, 2025 and published January 22, 2026, WO\/2026\/015983), which cover aspects of the ILF-RDT described herein.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"48"}}